METILPREDNISOLON ROMPHARM 250mg powder + solvent for injection medication leaflet

H02AB04 methylprednisolone • Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use, plain | Glucocorticoids

Methylprednisolone is a corticosteroid used to treat a wide range of inflammatory and autoimmune conditions. It is indicated for diseases such as rheumatoid arthritis, systemic lupus erythematosus, severe asthma, inflammatory bowel diseases (such as Crohn's disease or ulcerative colitis), severe allergies, dermatitis, multiple sclerosis, and certain types of cancer. It is also used to prevent organ rejection after transplantation.

Methylprednisolone works by suppressing the body's inflammatory and immune response, reducing inflammation, swelling, redness, and pain. It is available in the form of tablets, injectable solutions, or creams, and the method of administration depends on the condition being treated.

The dosage and duration of treatment are determined by the doctor based on the severity of the disease and the patient's response. It is important not to stop treatment abruptly, especially after long-term use, as this can lead to adrenal insufficiency.

Common side effects include increased appetite, weight gain, insomnia, irritability, high blood pressure, fluid retention, and weakened immune function. Long-term use may lead to osteoporosis, diabetes, skin thinning, or Cushing's syndrome.

Patients should strictly follow their doctor's instructions and inform their healthcare provider about other medications they are taking, as methylprednisolone can interact with other treatments. It is also important to avoid exposure to infections, as the medication can weaken the immune response.

General data about METILPREDNISOLON ROMPHARM 250mg

Substance: methylprednisolone

Date of last drug list: 01-06-2025

Commercial code: W69940001

Concentration: 250mg

Pharmaceutical form: powder + solvent for injection

Quantity: 1

Product type: generic

Price: 70.60 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ROMPHARM COMPANY S.R.L. - ROMANIA

Holder: ROMPHARM COMPANY S.R.L. - ROMANIA

Number: 15262/2024/01

Shelf life: 2 years-after packing for marketing;after reconstituting the solution-se utilizeaz? imediat

Concentrations available for methylprednisolone

1000mg, 125mg, 125mg/2ml, 16mg, 20mg, 250mg, 250mg/4ml, 32mg, 40mg, 40mg/1ml, 40mg/2ml, 40mg/ml, 4mg, 500mg, 500mg/7.8ml

Compensation lists for METILPREDNISOLON ROMPHARM 250mg ROMPHARM

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

70.60 RON

37.61 RON

32.99 RON

G14 (C1) - Multiple sclerosis

Price

Copayment

Patient

70.60 RON

70.60 RON

0.00 RON

G27 (C1) - Pemphigus

Price

Copayment

Patient

70.60 RON

70.60 RON

0.00 RON

G5 (C1) - Autoimmune hepatitis

Price

Copayment

Patient

70.60 RON

70.60 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

70.60 RON

70.60 RON

0.00 RON

NHP 7 (C2) - Endocrine diseases

Price

Copayment

Patient

70.60 RON

70.60 RON

0.00 RON

NHP 9.7 (C2) - Outpatient treatment of transplant patients

Price

Copayment

Patient

70.60 RON

70.60 RON

0.00 RON